Concepedia

Hengrui Liu

HL

Statistics

Publications

10

Citations

1.9K

H-Index

10

Active since

2018

Affiliations

Columbia University(Current)

Columbia University Irving Medical Center

Aaron Diamond AIDS Research Center

WuXi AppTec (United States)

Retrotope (United States)

Hengrui Liu is an author at Columbia University specializing in drug discovery, medicinal chemistry, and pharmacology.

ORCID

Publications per year

2018–2025

10

Publications

10

FINO2 initiates ferroptosis through GPX4 inactivation and iron oxidation

Michael M. Gaschler, Alexander A. Andia, Hengrui Liu et al. · Nature Chemical Biology · 2018 · 717 citations · Full text

, , +8

Imidazole Ketone Erastin Induces Ferroptosis and Slows Tumor Growth in a Mouse Lymphoma Model

Yan Zhang, Jacob D. Daniels, Fereshteh Zandkarimi et al. · Cell chemical biology · 2019 · 712 citations · Full text

, , +13

Lead compounds for the development of SARS-CoV-2 3CL protease inhibitors

Sho Iketani, F. Forouhar, Hengrui Liu et al. · Nature Communications · 2021 · 114 citations · Full text

, , +15

Characterization of a patient-derived variant of GPX4 for precision therapy

Hengrui Liu, F. Forouhar, Tobias Seibt et al. · Nature Chemical Biology · 2021 · 96 citations · Full text

, , +13

Development of optimized drug-like small molecule inhibitors of the SARS-CoV-2 3CL protease for treatment of COVID-19

Hengrui Liu, Sho Iketani, Arie Zask et al. · Nature Communications · 2022 · 96 citations · Full text

, , +17

1–5 of 10